| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.003 | 1 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.0035 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |